Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
| Image |  |
|---|---|
| Description | scientific article published in April 2014 |
| Author/s |
author: Catherine Llorens-Cortès |
| Publication date | April 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |